Articles and resources

Multiplex Real-time PCR Newborn Screening Assay to Simultaneously Identify Spinal Muscular Atrophy and Severe Combined Immunodeficiency
Newborn
26 May 2021

Multiplex Real-time PCR Newborn Screening Assay to Simultaneously Identify Spinal Muscular Atrophy and Severe Combined Immunodeficiency

Professor Mei Baker discusses Identifying Spinal Muscular Atrophy and Severe Combined Immunodeficiency using Real-time PCR newborn screening
PlGF and assessment of placental function in the first and third trimesters of pregnancy
Prenatal
14 May 2021

PlGF and assessment of placental function in the first and third trimesters of pregnancy

Professor Jon Hyett, Head of High-Risk Obstetrics and a Senior Staff Specialist in Obstetrics, and Maternal and Fetal Medicine Royal Prince Alfred Hospital, Sydney, Australia
First trimester prediction and prevention of pre-eclampsia
Prenatal
24 Apr 2021

First trimester prediction and prevention of pre-eclampsia

Kypros Nicolaides, Professor at King’s College Hospital, London (UK) and founder of Fetal Medicine Foundation (FMF) presents the latest development on predicition and prevention of preterm pre-eclampsia.
Idario Santos – Sweet Odyssey
Newborn
22 Apr 2021

Idario Santos – Sweet Odyssey

Idario Santos - talks about his sons journey with Maple Syrup Urine Disease - Sweet Odyssey
An innovative approach to sickle cell screening in Uganda – Interview with Charles Kiyaga
Newborn
22 Apr 2021

An innovative approach to sickle cell screening in Uganda – Interview with Charles Kiyaga

An innovative approach to sickle cell screening in Uganda - Interview with Charles Kiyaga
First years of experience on LSD screening in Italy, Padova
Newborn
22 Apr 2021

First years of experience on LSD screening in Italy, Padova

The increasing availability of treatments and the importance of early intervention have stimulated newborn screening (NBS) for lysosomal storage diseases (LSDs). We present our experience screening newborns in North East Italy to identify neonates with Mucopolysaccharidosis type I (MPS I) and Pompe, Fabry, and Gaucher diseases.
Minimizing Patients’ Risk of Adverse Outcomes in NIPT
Prenatal
26 Sep 2020

Minimizing Patients’ Risk of Adverse Outcomes in NIPT

Lawrence Prensky, MS, LCGC, CCGC, discusses the challenges within NIPT on one of the biggest stages in prenatal health, the CoGEN 2020 World Conference.
Making NIPT accessible to all women
Prenatal
26 Jun 2020

Making NIPT accessible to all women

This webinar aims to address some of the obstacles that have prevented the widescale adoption of NIPT. Issues such as: cost, focus, precision and ease of use will all be examined by our speakers and then reevaluated using PerkinElmer's new Vanadis® NIPT platform. Speakers include Prof. Howard Cuckle (Tel Aviv University, Israel) and Dr Alka Chaubey (PerkinElmer Global Genomic, USA)
Universal access to NIPT: Cost-effective and precise cell-free DNA testing
Prenatal
08 Jun 2020

Universal access to NIPT: Cost-effective and precise cell-free DNA testing

This PerkinElmer satellite symposium organized at the European Society of Human Genetics (ESHG) Virtual Conference 2020 presents two laboratories’ experience with Vanadis® NIPT, an automated, non-sequencing cell-free DNA testing platform. Speakers include Dr. Alka Chaubey (PerkinElmer Global Genomic, USA) and Prof. Barbara Pasini (University of Turin, Italy).
Implementation and Validation of a High-Precision, Non-NGS NIPT Platform
Prenatal
26 Sep 2018

Implementation and Validation of a High-Precision, Non-NGS NIPT Platform

This Genomeweb webinar provides a comprehensive overview of Vanadis® NIPT system, an automated, high-precision non-invasive prenatal testing platform. Speakers: Dr. Glenn Palomaki (Women & Infants Hospital, Rhode Island, USA) and Dr Jérémie Gautier (Cerba Xpert, France).

Products may not be licensed in accordance with the laws in all countries, such as the United States, Canada. Please check with your local representative for availability.

PerkinElmer does not endorse or make recommendations with respect to research, medication, or treatments. All information presented is for informational purposes only and is not intended as medical advice. For country specific recommendations please consult your local health care professionals.